Macquarie Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-11,697
| Closed | -$40K | – | 2479 |
|
|
2020
Q4 | $40K | Hold |
11,697
| – | – | ﹤0.01% | 2092 |
|
|
2020
Q3 | $17K | Hold |
11,697
| – | – | ﹤0.01% | 2197 |
|
|
2020
Q2 | $23K | Hold |
11,697
| – | – | ﹤0.01% | 2132 |
|
|
2020
Q1 | $23K | Hold |
11,697
| – | – | ﹤0.01% | 1904 |
|
|
2019
Q4 | $49K | Sell |
11,697
-438,303
| -97% | -$1.84M | ﹤0.01% | 1852 |
|
|
2019
Q3 | $1.36M | Hold |
450,000
| – | – | ﹤0.01% | 1132 |
|
|
2019
Q2 | $2.83M | Hold |
450,000
| – | – | ﹤0.01% | 924 |
|
|
2019
Q1 | $2.5M | Buy |
+450,000
| New | +$2.5M | ﹤0.01% | 941 |
|
|
2017
Q3 | – | Sell |
-104,566
| Closed | -$1.72M | – | 2145 |
|
|
2017
Q2 | $1.72M | Buy |
104,566
+36,300
| +53% | +$597K | ﹤0.01% | 1013 |
|
|
2017
Q1 | $979K | Sell |
68,266
-165
| -0.2% | -$2.37K | ﹤0.01% | 1186 |
|
|
2016
Q4 | $946K | Buy |
68,431
+12,531
| +22% | +$173K | ﹤0.01% | 1171 |
|
|
2016
Q3 | $1.01M | Buy |
+55,900
| New | +$1.01M | ﹤0.01% | 1146 |
|